Potential of nanoformulations in malaria treatment
JB Chaves, B Portugal Tavares de Moraes… - Frontiers in …, 2022 - frontiersin.org
Malaria is caused by the protozoan Plasmodium sp and affects millions of people worldwide.
Its clinical form ranges from asymptomatic to potentially fatal and severe. Current treatments …
Its clinical form ranges from asymptomatic to potentially fatal and severe. Current treatments …
Development of Curcumin nanophytosomes surface functionalized with Chondroitin sulfate-A for treating k1 Plasmodium falciparum drug-resistant malaria
E Bhargav, KB Koteshwara, YP Reddy… - Journal of Drug Delivery …, 2023 - Elsevier
The present study aimed to enhance the efficacy of Curcumin (CR) by a nanophytosomal
based drug delivery system. The DSPE-PEG-CSA lipid-polymer was synthesized and its …
based drug delivery system. The DSPE-PEG-CSA lipid-polymer was synthesized and its …
Exploring the efficacy of ethnomedicinal plants of Himalayan region against the malaria parasite
G Devi, V Gorki, NS Walter, S Sivangula… - Journal of …, 2024 - Elsevier
Ethnopharmacological relevance Plasmodium falciparum multi-drug resistant (MDR) strains
are a great challenge to global health care. This predicament implies the urgent need to …
are a great challenge to global health care. This predicament implies the urgent need to …
Development and Characterization of Novel Chitosan-Coated Curcumin Nanophytosomes for Treating Drug-Resistant Malaria
B Eranti, PR Yiragamreddy… - ASSAY and Drug …, 2024 - liebertpub.com
This study aimed at enhancing the efficacy of curcumin (CR) by formulating and coating it
with chitosan. In silico molecular docking studies revealed that CR exhibited almost similar …
with chitosan. In silico molecular docking studies revealed that CR exhibited almost similar …
A derivatization-based densitometric method for simultaneous estimation of artemether and lumefantrine: Method development, validation and applications
Cerebral malaria (CM) is a deadly neural disease caused by Plasmodium falciparum,
affecting predominantly the immunosuppressed people. A combination of artemether (AM) …
affecting predominantly the immunosuppressed people. A combination of artemether (AM) …